TY - JOUR
T1 - Assessment of diurnal melatonin, cortisol, activity, and sleep-wake cycle in patients with and without diabetic retinopathy
AU - Ba-Ali, Shakoor
AU - Brøndsted, Adam Elias
AU - Andersen, Henrik Ullits
AU - Sander, Birgit
AU - Jennum, Poul Jørgen
AU - Lund-Andersen, Henrik
N1 - Copyright © 2018 Elsevier B.V. All rights reserved.
PY - 2019/2
Y1 - 2019/2
N2 - Objective: To assess the diurnal melatonin, cortisol, and activity/rest levels, as well as sleep quality, in patients with and without nonproliferative diabetic retinopathy (DR). Methods: We included 25 diabetic patients with DR and 29 without DR. A total of 21 healthy subjects constituted the control group. We assessed the circadian rhythm by actigraphy and diurnal salivary melatonin and cortisol measurements. Sleep quality was evaluated by actigraphy and the Pittsburgh Sleep Quality Index (PSQI) and Epworth Sleepiness Scale (ESS) questionnaires. Light exposure was quantified by actigraphy. The primary outcome was peak salivary melatonin level. Secondary outcomes were mean melatonin and cortisol levels during dark hours, activity−rest rhythm, sleep quality, as well as level of white, red, green, and blue light exposure. Results: Peak melatonin concentration at 04:00 and mean nocturnal melatonin level were significantly reduced in all diabetic patients, regardless of retinopathy stage (p < 0.001). Levels of light exposures during dark hours were not significantly different in patients with and without DR and healthy controls. Only patients with DR showed increased intradaily variability in their activity−rest interval, indicating circadian misalignment (p = 0.04). Neither the objective actigraphic sleep quality parameters nor the subjective PSQI or ESS scores were significantly different between healthy controls and diabetic patients. Conclusions: Reduced nocturnal melatonin concentration and increased fragmentation of activity−rest intervals revealed circadian rhythm disturbance in diabetic patients with DR.
AB - Objective: To assess the diurnal melatonin, cortisol, and activity/rest levels, as well as sleep quality, in patients with and without nonproliferative diabetic retinopathy (DR). Methods: We included 25 diabetic patients with DR and 29 without DR. A total of 21 healthy subjects constituted the control group. We assessed the circadian rhythm by actigraphy and diurnal salivary melatonin and cortisol measurements. Sleep quality was evaluated by actigraphy and the Pittsburgh Sleep Quality Index (PSQI) and Epworth Sleepiness Scale (ESS) questionnaires. Light exposure was quantified by actigraphy. The primary outcome was peak salivary melatonin level. Secondary outcomes were mean melatonin and cortisol levels during dark hours, activity−rest rhythm, sleep quality, as well as level of white, red, green, and blue light exposure. Results: Peak melatonin concentration at 04:00 and mean nocturnal melatonin level were significantly reduced in all diabetic patients, regardless of retinopathy stage (p < 0.001). Levels of light exposures during dark hours were not significantly different in patients with and without DR and healthy controls. Only patients with DR showed increased intradaily variability in their activity−rest interval, indicating circadian misalignment (p = 0.04). Neither the objective actigraphic sleep quality parameters nor the subjective PSQI or ESS scores were significantly different between healthy controls and diabetic patients. Conclusions: Reduced nocturnal melatonin concentration and increased fragmentation of activity−rest intervals revealed circadian rhythm disturbance in diabetic patients with DR.
U2 - 10.1016/j.sleep.2018.10.018
DO - 10.1016/j.sleep.2018.10.018
M3 - Journal article
C2 - 30529775
SN - 1389-9457
VL - 54
SP - 35
EP - 42
JO - Sleep Medicine
JF - Sleep Medicine
ER -
